Suchergebnisse - "Lenalidomide"

PubPharm (3.678)

1

Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma

enthalten in: American journal of hematology | 2024

von Ludwig, H. | Melchardt, T. | Sormann, S. | +23

2

Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event reporting system

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Jedlowski, P. | DuPont, J.

3

Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B

enthalten in: Photodermatology, photoimmunology & photomedicine | 2024

von De Novellis, D. | Raimondo, A. | Serio, B. | +4

4

Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes : the HOVON89 trial

enthalten in: Leukemia | 2024

von van de Loosdrecht, A. | Cremers, E. | Alhan, C. | +37

5

Four-Drug Therapy for Multiple Myeloma

enthalten in: The New England journal of medicine | 2024

von Sampath, V.

CommentOn: N Engl J Med. 2024 Jan 25;390(4):301-313. - PMID 38084760

6

Four-Drug Therapy for Multiple Myeloma. Reply

enthalten in: The New England journal of medicine | 2024

von Sonneveld, P.

CommentOn: N Engl J Med. 2024 Jan 25;390(4):301-313. - PMID 38084760

7

Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level Data

enthalten in: Advances in therapy | 2024

von Durie, B. | Kumar, S. | Ammann, E. | +5

8

SuFEx-based chemical diversification for the systematic discovery of CRBN molecular glues

enthalten in: Bioorganic & medicinal chemistry | 2024

von Carter, T. | Milosevich, N. | Dada, L. | +4

9

Myelodysplastic syndromes del(5q) : Pathogenesis and its therapeutic implications

enthalten in: European journal of haematology | 2024

von Bruzzese, A. | Martino, E. | Mendicino, F. | +7

10

Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma

enthalten in: Journal for immunotherapy of cancer | 2024

von Coffey, D. | Osman, K. | Aleman, A. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[368]